Affymetrix Estimates Lowered and 4 Stock Analyses to Eye

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Transocean Ltd. (NYSE:RIG) reported higher operating EPS than predicted, and BMO Capital believes that the results are “messy but positive.” The firm views the stock’s valuation “very appealing,” and it keeps its Outperform rating on the stock.

Ventrus Biosciences, Inc. (NASDAQ:VTUS) stock dropped due to news that the FDA requested that the company conduct a second Phase III trial on its topical diltiazem for anal fissures. Cantor states that the news was expected, and it keeps its Outperform rating on the stock.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Affymetrix Inc. (NASDAQ:AFFX) estimates have been reduced by Maxim due to the company’s disappointing preliminary revenue results, but the company believes that shares are oversold currently. Maxim recommends using yesterday’s pullback as a buying opportunity, and it keeps its Buy rating on the stock.

Dollar Tree, Inc. (NASDAQ:DLTR) is believed by Morgan Stanley to have the ability to guide Q4 comps to flat to single digits, which may raise investor concerns. Shares have an Underweight rating and a $40 price target on the stock.

Elizabeth Arden, Inc. (NASDAQ:RDEN) guidance is believed by Sterne Agee to be conservative, and the firm keeps its Overweight rating on the stock.

Don’t Miss: Is Netflix Losing Its Edge?


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business